ANIX - Anixa Biosciences, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.38 -0.04 (-0.92%) --- 0.0 (0.0%) 0.03 (0.69%) 0.0 (0.0%) -0.04 (-0.92%) --- 0.0 (0.0%)

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.07
Diluted EPS:
-0.07
Basic P/E:
-61.9986
Diluted P/E:
-61.9986
RSI(14) 1m:
62.41
VWAP:
4.34
RVol:

Events

Period Kind Movement Occurred At

Related News